Synchron has acquired an equity stake in ACQUANDAS, a leading technology provider specializing in state-of-the-art high-precision components for the healthcare industry and other industries.

ACQUANDAS has established an entirely new generation of shape-memory, flexible metallic components suitable for use as medical devices. Their capability to manufacture miniaturized structures, such as micro-patterned Nitinol thin films, combined with high structure resolution and geometrical complexity, excellent biocompatibility and improved mechanical properties, provides Synchron with a unique product offering in the implantable medical device industry.

As we pioneer functional endovascular neurotechnology, this investment strengthens our technology innovation and supply chain for our unique product offerings, beginning with brain-computer interfaces,” said Tom Oxley, Synchron’s CEO & Founder, who will join the ACQUANDAS Governance Council.

en_GBEnglish (UK)